Sophie Poty - Publications

Affiliations: 
Memorial Sloan-Kettering Cancer Center, Rockville Centre, NY, United States 

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Al Ojaimi Y, Blin T, Lamamy J, Gracia M, Pitiot A, Denevault-Sabourin C, Joubert N, Pouget JP, Gouilleux-Gruart V, Heuzé-Vourc'h N, Lanznaster D, Poty S, Sécher T. Therapeutic antibodies - natural and pathological barriers and strategies to overcome them. Pharmacology & Therapeutics. 108022. PMID 34687769 DOI: 10.1016/j.pharmthera.2021.108022  0.317
2020 Poty S, Mandleywala K, O'Neill E, Knight JC, Cornelissen B, Lewis JS. Zr-PET imaging of DNA double-strand breaks for the early monitoring of response following α- and β-particle radioimmunotherapy in a mouse model of pancreatic ductal adenocarcinoma. Theranostics. 10: 5802-5814. PMID 32483420 DOI: 10.7150/Thno.44772  0.437
2019 Sharma SK, Lyashchenko SK, Park HA, Pillarsetty N, Roux Y, Wu J, Poty S, Tully KM, Poirier JT, Lewis JS. A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals. Nuclear Medicine and Biology. 71: 32-38. PMID 31128476 DOI: 10.1016/J.Nucmedbio.2019.04.005  0.477
2019 Curado N, Dewaele-Le Roi G, Poty S, Lewis JS, Contel M. Trastuzumab gold-conjugates: synthetic approach and in vitro evaluation of anticancer activities in breast cancer cell lines. Chemical Communications (Cambridge, England). PMID 30632546 DOI: 10.1039/C8Cc08769E  0.327
2019 Poty S, Knight JC, Donabedian P, Mandleywala K, Cornelissen B, Reiner T, Lewis JS. PET Imaging of DNA Damage Response following 225Ac-radioimmunotherapy in a Pancreatic Ductal Adenocarcinoma Mouse Model Journal of Medical Imaging and Radiation Sciences. 50: S4-S5. DOI: 10.1016/J.Jmir.2019.03.014  0.468
2018 Poty S, Carter LM, Mandleywala K, Membreno R, Abdel-Atti D, Ragupathi A, Scholz WW, Zeglis BM, Lewis JS. Leveraging bioorthogonal click chemistry to improve 225Ac-radioimmunotherapy of pancreatic ductal adenocarcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30352909 DOI: 10.1158/1078-0432.Ccr-18-1650  0.553
2018 Poty S, Francesconi LC, McDevitt MR, Morris MJ, Lewis JS. Alpha Emitters for Radiotherapy: Basic Radiochemistry to Clinical Studies _ Part 1. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29545378 DOI: 10.2967/Jnumed.116.186338  0.32
2018 Poty S, Francesconi LC, McDevitt MR, Morris MJ, Lewis JS. Alpha Emitters for Radiotherapy: Basic Radiochemistry to Clinical Studies - Part 2. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29496984 DOI: 10.2967/Jnumed.117.204651  0.303
2018 Carter LM, Poty S, Sharma SK, Lewis JS. Preclinical Optimization of Antibody-based Radiopharmaceuticals for Cancer Imaging and Radionuclide Therapy - Model, Vector, and Radionuclide Selection. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 29412489 DOI: 10.1002/Jlcr.3612  0.505
Show low-probability matches.